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ABSTRACT: Haloalkane dehalogenase (DhlA) catalyzes the hydrolysis of haloalkanes Via an alkyl-enzyme
intermediate. The covalent intermediate, which is formed by nucleophilic substitution with Asp124, is
hydrolyzed by a water molecule that is activated by His289. The role of Asp260, which is the third
member of the catalytic triad, was studied by site-directed mutagenesis. Mutation of Asp260 to asparagine
resulted in a catalytically inactive D260N mutant, which demonstrates that the triad acid Asp260 is essential
for dehalogenase activity. Furthermore, Asp260 has an important structural role, since the D260N enzyme
accumulated mainly in inclusion bodies during expression, and neither substrate nor product could bind
in the active-site cavity. Activity for brominated substrates was restored to D260N by replacing Asn148
with an aspartic or glutamic acid. Both double mutants D260N+N148D and D260N+N148E had a 10-
fold reduced kcat and 40-fold higher Km values for 1,2-dibromoethane compared to the wild-type enzyme.
Pre-steady-state kinetic analysis of the D260N+N148E double mutant showed that the decrease in kcat
was mainly caused by a 220-fold reduction of the rate of carbon-bromine bond cleavage and a 10-fold
decrease in the rate of hydrolysis of the alkyl-enzyme intermediate. On the other hand, bromide was
released 12-fold faster and Via a different pathway than in the wild-type enzyme. Molecular modeling of
the mutant showed that Glu148 indeed could take over the interaction with His289 and that there was a
change in charge distribution in the tunnel region that connects the active site with the solvent. On the
basis of primary structure similarity between DhlA and other R/â-hydrolase fold dehalogenases, we propose
that a conserved acidic residue at the equivalent position of Asn148 in DhlA is the third catalytic triad
residue in the latter enzymes.
Haloalkane dehalogenase (DhlA)1 from Xanthobacter
autotrophicus GJ10 is able to cleave carbon-halogen bonds
hydrolytically in a broad range of haloalkanes, some of which
are notorious environmental pollutants (Keuning et al., 1985).
Its three-dimensional structure, which was solved by X-ray
crystallography (Verschueren et al., 1993a), consists of two
domains: a main domain with an R/â-hydrolase fold
structure and an R-helical cap domain lying on top of the
main domain. The active site is a mainly hydrophobic cavity
that is positioned between the two domains and contains the
catalytic triad residues Asp124, His289, and Asp260.
The reaction mechanism consists of four main steps
(Scheme 1) as was determined by X-ray crystallographic and
site-directed mutagenesis studies (Verschueren et al., 1993b;
Pries et al., 1994, 1995). In the first step the substrate binds
in the cavity and a Michaelis complex (EâRX) is formed in
which the ClR is stabilized by interactions with the NH groups
of the Trp125 and Trp175 side chains. This is followed by
a nucleophilic attack of Asp124 on the halogen-bound C1
atom of the substrate, leading to the formation of a covalent
alkyl-enzyme intermediate and a halide ion, which remains
bound between the two Trp residues (E-RâX-). The
intermediate is subsequently hydrolyzed by a water molecule
activated by the general base His289. The alcohol leaves
the active site as soon as it is formed (EâX-), and finally,
the halide ion is released from the cavity. Recent pre-steady-
state kinetic studies showed that halide export proceeds Via
a complex pathway and is the main rate-determining step in
the conversion of 1,2-dichloroethane and 1,2-dibromoethane
(Schanstra & Janssen, 1996).
The role of Asp260, the third member of the catalytic triad,
is not yet fully understood. The triad acid is hydrogen-
bonded to His289 and may assist the histidine in its function
as a general base by stabilizing the positive charge on the
imidazole ring that emerges as the histidine extracts a proton
from the water molecule. It may well be that Asp260 is
necessary for hydrolysis of the alkyl-enzyme and that the
covalent intermediate is trapped by removing the aspartic
acid. In addition, Asp260 may have a structural role, e.g.,
by influencing the positioning of the active-site histidine or
by stabilizing the active-site cavity geometry.
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fold family; a group of hydrolytic enzymes that share a
similar topology and a preserved arrangement of the catalytic
triad residues (Ollis et al., 1992). The topological positions
of the nucleophile Asp124 and the general base His289 after
â-strand 5 and 8, respectively, are fully conserved within
this family, while the location of the third catalytic residue
Asp260 is not (Schrag et al., 1992). In haloalkane dehalo-
genase, Asp260 is located in a loop after â-strand 7 (Figure
1), but in human pancreatic lipase, for instance, the equivalent
of this residue lies after â-strand 6 (Schrag et al., 1992). At
that position Asn148 is present in haloalkane dehalogenase
(Figure 1). The three-dimensional structure shows that
Asn148 is in the proximity of His289 and that the carboxyl
group can be brought into hydrogen-bonding distance with
the histidine by a simple rotation around torsion angles ø1
and ø2. This raises the question whether an aspartic or
glutamic acid at position 148 can take over the role of
Asp260, and thus whether the catalytic triad can be modified.
Here we report the results of studies in which we examined
the role of the catalytic triad acid Asp260 in haloalkane
dehalogenase by site-directed mutagenesis. On the basis of
sequence alignments and the X-ray structure, we shifted
Asp260 to position 148 by mutating Asp260 to an asparagine
and replacing Asn148 by an aspartic or glutamic acid. In
addition, we studied the effects of these mutations on
dehalogenase stability, kinetics, and structure.
MATERIALS AND METHODS
Materials. Restriction enzymes, Klenow enzyme, T4
ligase, and isopropyl â-D-thiogalactopyranoside (IPTG) were
obtained from Boehringer Mannheim. Bacteriophage R408,
T7 polymerase, and DNA sequencing reagents were obtained
from Pharmacia LKB Biotechnology. Monodeoxyribo-
nucleoside 5¢-triphosphates (dNTPs) were purchased from
Promega, [R-35S]dATP from Amersham Lifescience, and the
oligonucleotides for site-directed mutagenesis and sequencing
were synthesized by Eurosequence (Groningen, The Neth-
erlands). Halogenated compounds were obtained from
Janssen Chimica or from Merck. 2H2O (99.8% v/v) was
purchased from Merck or from Isotec Inc.
Bacterial Strains and Plasmids. Escherichia coli strain
BW313 (Kunkel et al., 1985) was used for the production
of uracil-containing single-stranded DNA in site-directed
mutagenesis, E. coli JM101 (Promega) was used for standard
DNA manipulations and the production of single-stranded
DNA for sequencing, and E. coli KA1276 (dam-) was used
to screen transformants with the endonuclease BclI. E. coli
strain BL21(DE3) (Studier et al., 1990) was the bacterial
host used for overexpression of the mutant dehalogenases.
The plasmid pGELAF+ was used to construct mutants of
haloalkane dehalogenase. pGELAF+ is a mutagenesis and
expression vector based on pET-3d (Studier et al., 1990) with
the wild-type dehalogenase gene (dhlA) under the control
of the T7 promoter and an additional f1+ origin for the
production of single-stranded DNA (Schanstra et al., 1993).
Site-Directed Mutagenesis. All standard molecular DNA
techniques such as DNA preparation, restriction analysis, and
electroporation were performed as described by Sambrook
et al. (1989). Mutants of haloalkane dehalogenase were
constructed according to the Kunkel method (Kunkel, 1985).
The mutagenic primer used to change Asp260 to Asn was
5¢-ggcatgaaaaacaaattgctggg-3¢ (codon for amino acid 260 in
boldface type), and for Asn148 to Asp or Glu, 5¢-cgcctgatta-
tcatggaa(c)gcctgcttga-3¢ (removed BclI restriction site un-
derlined and codon of amino acid 148 in boldface type).
pGELAF+ and pGELAF+D260N were used as templates
to obtain single and double mutants, respectively. Trans-
formants were screened initially for loss or regain of activity
FIGURE 1: Stereoview of the active site of haloalkane dehalogenase. The MOLSCRIPT (Kraulis, 1991) representation includes strands 3,
5, 6, 7, and 8 of the central eight-stranded â-sheet, Asn148, the catalytic triad residues Asp124, His289, and Asp260, and the halide-binding
residues Trp125 and Trp175.
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of particular restriction sites. DNA sequences were con-
firmed by the dideoxy chain-termination method (Sanger et
al., 1977).
Protein Expression and Purification. The dehalogenase
enzymes were expressed and purified as described earlier
by Schanstra et al. (1993). The buffers used during purifica-
tion were T10EMAG [10 mM Tris-sulfate pH 7.5, 1 mM
EDTA, 1 mM 2-mercaptoethanol, 3 mM sodium azide, and
10% (v/v) glycerol] and P5EMAG [5 mM potassium phos-
phate pH 6.5, 1 mM EDTA, 1 mM 2-mercaptoethanol, 3
mM sodium azide, and 10% (v/v) glycerol]. The enzymes
were concentrated with an Amicon ultrafiltration cell using
a PM30 filter. Coomassie brilliant blue was used to
determine protein concentrations of crude extracts with
bovine serum albumin as a standard. The concentration of
purified enzyme was measured by its absorbance at 280 nm
(280 ) 4.87  104 M-1 cm-1). The purity of the isolated
enzymes was analyzed by SDS-polyacrylamide gel elec-
trophoresis.
Steady-State Kinetics. Dehalogenase assays were carried
out using colorimetric detection of halide release as described
previously by Keuning et al. (1985). Solvent kinetic isotope
effects were determined by performing dehalogenase assays
in buffers containing 2H2O concentrations ranging from 0
to 90%.
For the determination of Km, Vmax, and kcat/Km, a suitable
amount of enzyme was incubated at 30 °C in 4.5 mL of 50
mM Tris-sulfate buffer (pH 8.2) containing varying substrate
concentrations. The amount of halide produced was deter-
mined colorimetrically (Keuning et al., 1985) and the alcohol
production was analyzed on a Chrompack 438S gas chro-
matograph with a Chrompack CP Wax 52CB column. An
ECD- and an FID-detector were used to detect brominated
and chlorinated compounds, respectively. The carrier gas
was nitrogen (60 kPa), and the temperature program was 3
min isothermal at 45 °C followed by an increase of 10 °C/
min to 250 °C. Km and Vmax values were calculated from
the alcohol and halide production rates by nonlinear regres-
sion analysis using the Michaelis-Menten equation and the
Enzfitter program of Leatherbarrow (1987).
Circular Dichroism Spectra. Circular dichroism spectra
were recorded by using an Aviv 62A DS spectrometer. Data
were collected at 25 °C from 190 to 250 nm using a 0.1-cm
cuvette containing 0.3 mg/ml of dehalogenase in 5 mM
potassium phosphate buffer (pH 7.5). Each spectrum shown
is the average of five individual scans and was corrected for
absorbance caused by the buffer. CD data were expressed
in terms of the mean residue ellipticity (£MRE) using
where £obs is the observed ellipticity in degrees, Mw is the
protein molecular weight of 35 143, n is the number of
residues (310), l is the cell path length of 0.1 cm, c is the
protein concentration in milligrams per milliliter, and the
factor of 100 originates from the conversion of the molar
weight to milligrams per decimole (Schmid, 1990).
Steady-State Halide Binding. Steady-state halide binding
was examined by fluorescence quenching measurements at
30 °C using an SLM Aminco SPF500-C spectrofluorometer
as described previously (Verschueren et al., 1993c). Enzyme
solutions of 1 íMi nT 50EMAG buffer (pH 8.2) were used
and halides were added from NaBr and NaCl stock solutions
prepared in the same buffer as the enzyme. The excitation
wavelength was 290 nm and spectra were recorded in the
range of 300-450 nm. The data were corrected for dilution
and apparent halide dissociation constants (Kd) were calcu-
lated using nonlinear regression fitting (SigmaPlot, Jandel
Scientific) of
where F is the observed fluorescence at halide concentration
[X-], Kd is the apparent dissociation constant, and fa is the
fraction of the total fluorescence that is quenched at [X-] .
Kd.
Transients Kinetics. The kinetics of halide and substrate
binding were determined at 30 °C by stopped-flow fluores-
cence quenching experiments using an Applied Photophysics
SX17MV stopped-flow instrument. Tryptophan fluorescence
was excited at 290 nm and the emission was monitored after
passage through a 320-nm cutoff filter. All reactions were
performed in T50EMAG buffer (pH 8.2) and the reported
reactant concentrations are those in the reaction chamber after
mixing. Each kinetic trace shown is the average of four
individual experiments and could be fitted with a computer
program supplied by the instrument’s manufacturer to the
single-exponential model
in which R is the amplitude and kobs is the observed rate.
Kinetic data were then further analyzed using the spreadsheet
program Quattro-Pro (Borland International Inc.).
Rapid-Quench Studies. Rapid-quench experiments were
performed in T50ED buffer (50 mM Tris-SO4,p H8 . 2 ,1m M
EDTA, and 1 mM dithiothreitol) at 30 °C using an RQF-63
rapid-quench instrument from KinTek Corporation. Reac-
tions were initiated by mixing 50 íL of 1.8 mM dehalogenase
with 50 íL of 0.5 mM 1,2-dibromoethane (DBE) in the case
of single-turnover measurements or with 50 íLo f2 0m M
DBE in the case of multiple-turnover studies. The reactions
were quenched after reaction times ranging from 150 ms to
15 s with 120 íLo f0 . 8MH 2 SO4. Quenched reaction
samples were directly ejected into 1.5 mL of ice-cold diethyl
ether, containing 0.05 mM 1-bromohexane as the internal
standard, and thoroughly mixed. The diethyl ether phase
containing noncovalently bound DBE and 2-bromo-
ethanol was separated from the water phase, neutralized by
addition of H2CO3, and analyzed by gas chromatography as
described for the Km determinations. All concentrations
reported are those in the reaction loop of the rapid-quench
instrument.
Rates and equilibrium constants for substrate conversion
were derived from rapid-quench data by numerical simulation
of Scheme 1, using the computer program Gepasi (Mendes,
1993; Gepasi for MS-Windows, version 2.0, release 2.08).
The fits were constrained by the experimentally determined
steady-state kcat and Km values and by the fact that kcat/Km
sets the lower limit for k1 (Fersht, 1985). The Gepasi output
was analyzed with the spreadsheet program Quattro-Pro
(Borland International Inc.) to check whether the numerical
simulations fitted the experimental data correctly. Under
£MRE )
£obsMw(100)
nlc
(1)
(F0 - F)
F0
)
fa[X
-]
[X
-] + Kd
(2)
F )R (1 - e
-kobst) (3)
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These equations were derived using the determinant method
described by Huang (1979).
Molecular Modeling. A model of the double mutant
D260N+N148E was built on a SGI Power-Challenge XL
computer using the Insight II modeling package (Biosym/
MSI Inc., San Diego, CA). The X-ray structure of halo-
alkane dehalogenase at pH 8.2 (PDB access code 1ede) was
used as a starting model. The protein was protonated at pH
8.0 using the Builder module of the Insight II program. The
N2 atom of His289 was left unprotonated and the hydrogen
atoms of the catalytic water molecule (H2O 402) were
positioned to form hydrogen bonds with His289N2 and
Asp124Oä1 as proposed by Verschueren et al. (1993a). All
minimizations were performed using the CVFF force field
of the Discover 95.0/3.00 program. The wild-type structure
was relaxed prior to the modeling experiments by use of the
following procedure: (i) the protein was soaked by a water
layer of 5 Å, 1000 steps of steepest descent, tethered all
heavy atoms; (ii) 3000 steps of steepest descent, tethered
backbone; (iii) solvent molecules removed except for the
catalytic water H2O 402, 1000 steps of steepest descent, no
tethering; (iv) 10 000 steps of conjugate gradient, no tether-
ing. The two substitutions Asp260Asn and Asn148Glu were
made in the Biopolymer module of Insight II and the
substituted side chains were positioned with 4000 steps of
conjugate gradient minimization.
To model protein-substrate complexes, a 1,2-dichloro-
ethane molecule (DCE) was placed into the active site of
the relaxed wild-type structure and the model of the double
mutant at a position that was analogous to the position of
DCE in the haloalkane dehalogenase-DCE structure (Ver-
schueren et al., 1993b; PDB entry 2dhc). The complexes
were minimized by an additional 3000 steps using the
conjugate gradient algorithm.
RESULTS
Sequence Alignment of R/â-Hydrolase Fold Dehalogena-
ses. Sequence analysis of haloacid dehalogenase from
Moraxella B (DehH1, Genbank/EMBL Accession Number
D90422; Kawasaki et al., 1992), tetrachlorocyclohexadiene
dehalogenase from Sphingomonas paucimobilis (LinB,
D14594; Nagata et al., 1993), and 1-chloroalkane halidohy-
drolase from Rhodococcus rhodochrous NCIMB13064 (DhaA,
L49435; Kulakova et al., 1997) showed that they have
considerable homology with DhlA (M26950), suggesting
FIGURE 2: Sequence alignment of haloalkane dehalogenase from Xanthobacter autotrophicus GJ10 (DhlA; Janssen et al., 1989), haloacid
dehalogenase from Moraxella B (DehH1; Kawasaki et al., 1992), tetrachlorocyclohexadiene dehalogenase from Sphingomonas paucimobilis
(LinB; Nagata et al., 1993), and 1-chloroalkane halidohydrolase from Rhodococcus rhodochrous NCIMB13064 (DhaA; Kulakova et al.,
1997). The sequence comparison was carried out using the program DNASTAR (DNASTAR Inc., Madison, WI). Symbols indicate the
following: an asterisk, identity for all four proteins; a dot, functionally homologous residues for all four proteins. Residues in boldface
type indicate identity in at least three proteins. R and â indicate residues in R-helices and â-strands of DhlA, respectively. A spade
indicates the conserved nucleophilic Asp in the proteins, a clover indicates the conserved general base His, a diamond shows the position
of Asp260 in DhlA, and a downward arrow shows the position of Asn148 in DhlA.
kcat )
k2k3kx
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the regions around the nucleophilic Asp124 and general base
His289 appear to be very similar. However, the third residue
in the catalytic triad, which is Asp260 in DhlA, does not
seem to be conserved in the other dehalogenases considering
the lack of homology and the absence of an acidic amino
acid in this region. On the other hand, more similarity is
found around Asn148, which is located in DhlA after
â-strand 6 at the equivalent position of the triad acid in
human pancreatic lipase. This suggests that the third residue
in the catalytic triad may be present in DehH1, LinB, and
DhaA at a position analogous to Asn148. Therefore, we
determined whether the catalytic triad in DhlA could be
modified by changing Asp260 into an asparagine and Asn148
into an aspartic acid, and we examined the effects of the
mutations on activity and kinetics.
Site-Directed Mutagenesis and Analysis of Specific ActiVi-
ties. The Kunkel method was used to construct the single
mutants D260N, N148D, and N148E and the double mutants
D260N+N148D and D260N+N148E. The mutated en-
zymes were overexpressed in E. coli BL21(DE3) to levels
comparable to that of overexpressed wild-type DhlA.
The D260N mutant protein appeared to be mainly present
in inclusion bodies, suggesting that this mutant is less stable
or shows less efficient folding than the wild-type protein.
Activity measurements showed that D260N dehalogenase
was unable to convert brominated or chlorinated substrates,
indicating that Asp260 is essential for dehalogenase activity.
The single mutants N148D and N148E are also inactive
toward chlorinated alkanes and show largely reduced activi-
ties for all brominated substrates tested (Table 1). Moreover,
both N148 single mutants were less stable than the wild-
type enzyme. They lost their catalytic activity fairly rapidly
(about 50% in a week), even when stored at 4 °Ci nt h e
presence of 10% glycerol.
Both double mutants appeared to have partially restored
activities for brominated compounds compared with the
catalytically inactive D260N single mutant (Table 1) and
showed wild-type stability. The highest activity was found
with 1,2-dibromoethane (DBE), which was about 10% of
the wild-type activity for both double mutants. They
remained inactive for all chlorinated compounds tested,
however.
Analysis of Secondary Structure. The integrity of the
secondary structure was tested for the D260N and
D260N+N148E mutants by circular dichroism and fluores-
cence spectroscopy. As shown in Figure 3, like the wild-
type dehalogenase, both mutants had the double ellipticity
minimum at 210 and 222 nm, characteristic of R-helical
content (Schmid, 1990). Yet D260N exhibited a less intense
minimum at 222 nm than the wild type and double mutant,
suggesting a decrease in the number of amino acids in
R-helical conformation. The tryptophan fluorescence spec-
trum of this inactive enzyme, however, is exactly the same
as the one of wild-type dehalogenase (data not shown),
indicating that the proposed change in R-helical content did
not disturb the overall structure of the enzyme dramatically.
Steady-State Kinetics and Halide Binding. The dehalo-
genase mutants D260N, N148D, D260N+N148D, and
D260N+N148E were purified and steady-state kinetic
parameters were determined using DBE as the substrate
(Table 2). The activity of the D260N dehalogenase was too
low for kinetic analysis. Km values obtained for the other
mutants were 40-fold higher than the wild-type value, and
the kcat was reduced 90-fold for the N148D mutant and at
least 1000-fold for the D260N single mutant. Introduction
of an acidic amino acid at position 148 in the single mutant
D260N resulted in a considerable improvement of the kcat
Table 1: Activities of Wild-Type and Mutant Haloalkane Dehalogenases in Crude Extractsa
activity (milliunits/mg)
substrate concn (mM) wild type N148D N148E D260N+N148D D260N+N148E
1,2-dibromoethane 5 3170 75 280 150 300
1-bromopropane 5 1050 b 50 20 100
1,2-dibromopropane 5 1500 10 30 10 40
1-bromo-2-chloroethane 5 3270 65 240 90 200
dibromomethane 5 3250 65 280 120 280
1,2-dichloroethane 30 4230 b 65 bb
1,2-dichloropropane 15 95 b <10 bb
a The crude extracts were produced from late-exponential, induced cultures grown at 17 °C. The expression levels ranged from 30% to 60% of
the total protein contents of cell-free extract. b Not detectable (<5 milliunits/mg).
FIGURE 3: Far-UV circular dichroism spectra of wild-type halo-
alkane dehalogenase (dashed line), D260N mutant (solid line), and
D260N+N148E mutant (dotted line) in 5 mM phosphate buffer,
pH 7.5. The spectra were measured on an Aviv 62A DS
spectrometer at 25 °C and the protein concentration was 0.3 mg/
mL, as described in Materials and Methods.
Table 2: Bromide-Binding and Steady-State Activity Parameters of
Purified Wild-Type and Mutated Haloalkane Dehalogenasesa for
1,2-Dibromoethane at pH 8.2 and 30 °C
Km
(mM)
kcat
(s-1)
kcat/Km
(M-1 s-1)
Kd
(mM) fa kH/kD
b
wild typec 0.01 3.0 3.0  105 10 0.34 2
N148D 0.36 0.04 110 >500 4
D260N+N148D 0.38 0.23 600 100 0.15 2
D260N+N148E 0.43 0.35 810 110 0.15 3
a No steady-state parameters could be determined for the D260N
mutant, since it was catalytically inactive. b Solvent (D2O) kinetic
isotope effect on dehalogenase activity. kH and kD are the kcat values
determined in H2O and 90% D2O, respectively. c Taken from Schanstra
et al. (1996).
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although the kcat values remained 10-fold lower than with
the wild-type enzyme.
A solvent kinetic isotope effect of 2H2Oo nt h ek cat of DBE
conversion, as was seen for wild-type DhlA (Schanstra et
al., 1996; Schanstra & Janssen, 1996), was also observed
for both double mutants and the N148D enzyme (Table 2).
This suggested that the rate-determining reaction step might
be either the hydrolysis of the alkyl-enzyme intermediate
(k3 in Scheme 1) or halide release (kx in Scheme 1).
Tryptophan fluorescence quenching studies were per-
formed with bromide and chloride at pH 8.2. The calculated
dissociation constants (Kd) and fractional accessibilities (fa)
are listed in Table 2. Chloride dissociation constants could
not be determined for any of the mutants, since chloride ions
hardly caused fluorescence quenching, suggesting that
chloride did not bind between Trp125 and Trp175.
No significant quenching by bromide ions or substrate was
observed for the catalytically inactive D260N haloalkane
dehalogenase, suggesting that neither bromide ions nor
substrate could bind in the active site.
The affinity for bromide ions decreased about 10-fold for
the double mutants and more than 10-fold for the N148D
single mutant. Both double mutants showed a lower degree
of quenching (fa) for bromide ions compared with the wild-
type enzyme, suggesting that at least one of the tryptophans
in the halide-binding site has a reduced interaction with the
halide.
Pre-Steady-State Kinetic Analysis of 1,2-Dibromoethane
ConVersion by D260N+N148E Dehalogenase. The most
active DhlA double mutant D260N+N148E was used to
study the pre-steady-state kinetics of DBE conversion to find
out why the double mutants display a lower kcat and higher
Km than the wild-type dehalogenase.
To identify the rate-determining step in DBE conversion,
a rapid-quench experiment was performed with substrate in
excess over enzyme (Figure 4A). A clear lag in the
production of 2-bromoethanol was observed, meaning that
the rate-determining step should precede halide release.
Apparently, the rate-determining step has shifted in the
double mutant, since halide release is the slowest step in
the wild-type enzyme. A steady-state 2-bromoethanol
production rate of 0.32 s-1 could be deduced from the
multiple-turnover experiment (Figure 4A), which was nearly
identical to the steady-state kcat derived from measurements
of halide production rates (0.35 s-1, Table 2).
Insight in the kinetics of the reaction steps preceding halide
export was obtained from a single-turnover rapid-quench
experiment in which enzyme (900 íM) was in excess over
substrate (250 íM) (Figure 4A). Consumption of substrate
and production of 2-bromoethanol occurred at approximately
the same speed, indicating that the rate of formation of the
alkyl-enzyme was lower than the rate of its hydrolysis and
that the covalent intermediate hardly accumulated during the
reaction.
The rates of the individual reaction steps were calculated
by numerical simulation of the four-step reaction mechanism
in Scheme 1, together with the rapid-quench data and the
steady-state kcat and Km (Table 3, fits in Figure 4A). The
slowest steps in the conversion of 1,2-dibromoethane ap-
peared to be carbon-bromine bond cleavage (k2) and
hydrolysis of the covalent intermediate (k3), which showed
a reduction of at least 220-fold for k2 and 10-fold for k3
compared with the wild-type values. The rate of bromide
release (kx) was higher than with the wild-type, since kx had
to be set higher than 10 s-1 to establish a good fit. Therefore,
k2 and k3 together account for the change in steady-state kcat.
The increase of the Km in the mutant may be caused by the
lowered value for k2. The kcat and Km calculated from the
rates of the individual steps were in good agreement with
kcat and Km determined from steady-state experiments (Table
3).
The numerical simulation procedure did not provide exact
rates for substrate binding and release (k1 and k-1). Only
the ratio between k1 and k-1 could be extracted from the
data, indicating that the first step may be mechanistically
complex. Direct measurement of DBE binding did not yield
Table 3: Pre-Steady-State Kinetic Parameters of Purified Wild-Type and Mutated Haloalkane Dehalogenases for 1,2-Dibromoethane at pH 8.2
and 30 °C
k1
(íM-1 s-1)
k-1
(s-1)
k2
(s-1)
k3
(s-1)
kx
(s-1)
kcat calca
(s-1)
kcat expb
(s-1)
Km calca
(íM)
Km expb
(íM)
kcat/Km expb
(íM-1 s-1)
wild type (H2O)c 0.75 ( 0.1 >20 >130 10 ( 24 ( 1.5 2.8 3 5.6 10 0.30
wild type (D2O)c 0.75 ( 0.1 >20 >130 4 ( 13 ( 0.5 1.7 1.5 2.6 4.3 0.35
D260N+N148E (H2O) k-1/k1 700 íM 0.55 ( 0.05 0.8 ( 0.1 >10 0.32 0.35 420 430 8.0  10-4
D260N+N148E (D2O) k-1/k1 400 íM 0.3 ( 0.1 0.2 ( 0.02 >5 0.14 0.12 180 140 8.5  10-4
a Calculated from the rate constants given. b Parameters obtained from steady-state experiments. c Taken from Schanstra et al. (1996).
FIGURE 4: Rapid-quench analysis of the reaction of haloalkane
dehalogenase double mutant D260N+N148E with 1,2-dibromo-
ethane. (A) Upper panel: Multiple turnover of 0.9 mM dehalo-
genase with 10 mM 1,2-dibromoethane in T50ED buffer, pH 8.2.
Lower panel: Single turnover of 0.9 mM dehalogenase with 0.25
mM 1,2-dibromoethane in T50ED buffer, pH 8.2. (B) Upper
panel: Multiple turnover of 1.0 mM dehalogenase with 10 mM
1,2-dibromoethane in T50ED buffer, pH 8.2, in 90% D2O. Lower
panel: Single turnover of 1 mM dehalogenase with 0.75 mM 1,2-
dibromoethane in T50ED buffer, pH 8.2, in 90% D2O. 2-Bromo-
ethanol production (b) and 1,2-dibromoethane consumption (O)
are shown. The solid curves are numerical fits generated by the
Gepasi program. The dotted lines represent the simulated concen-
trations of the alkyl-enzyme intermediate in time.
9576 Biochemistry, Vol. 36, No. 31, 1997 Krooshof et al.absolute values, because of aspecific quenching of enzyme
fluorescence at high substrate concentration.
Bromide Binding and Release. The kinetics of bromide
binding and release were studied in more detail by stopped-
flow fluorescence experiments in which enzyme (5 íM) was
mixed rapidly with various concentrations of NaBr (10-
1000 mM). The results confirmed that bromide binding
proceeds much faster than in wild-type DhlA (Figure 5). The
fluorescence transients could all be fitted by single-
exponential equations, which gave an apparent bromide
binding rate (kobs) for each bromide concentration (Figure
5A). Unlike in the wild-type enzyme, the bromide concen-
tration dependence of kobs in the D260N+N148E double
mutant approximates a hyperbola (Figure 5B), which indi-
cates that binding of bromide to the mutant DhlA occurs in
two steps: a fast bimolecular step (rapid equilibrium) in
which a collision complex is formed, followed by a slow
unimolecular step (e.g., some isomerization leading to a
tighter binding of the halide) (Figure 6, lower pathway).
For this two-step bromide binding pathway, the observed
binding rate (kobs) and apparent dissociation constant (Kd)
are given by
The maximum rate is equal to the sum of k5 + k-5, and the
intercept on the y-axis is equal to the rate constant k-5,
defining the halide dissociation rate (kx in Scheme 1).
The results of fitting the hyperbola with eq 7 (Figures 5B
and 6) demonstrate that the D260N+N148E double mutant
releases bromide 12-fold more rapidly than wild-type de-
halogenase (kx ) 4s - 1). The calculated Kd is similar to the
Kd obtained from steady-state fluorescence measurements
(Table 2).
Pre-Steady-State Experiments in the Presence of 2H2O.
The fact that carbon-bromine bond cleavage limited the
overall conversion rate of DBE in the D260N+N148E
dehalogenase mutant could not explain the solvent kinetic
isotope effect observed on the kcat of this mutant. Therefore,
rapid-quench experiments were performed using 2H2Oa st h e
solvent (Figure 4B).
The solvent clearly affected the steady-state production
of 2-bromoethanol and the initial lag phase when the enzyme
was mixed with excess DBE (Figure 4B). The steady-state
turnover rate calculated from the last part of the curve was
0.14 s-1, which was similar to the kcat in 2H2O (Table 3).
2H2O did not seem to influence the consumption rate of the
substrate in a single-turnover experiment, while 2-bromo-
ethanol production was slowed down (Figure 4B). This
would suggest that k3 and kx are affected, whereas k1, k-1,
and k2 are not.
Determination of the individual rate constants from nu-
merical simulation of Scheme 1, as was done with experi-
ments in 1H2O, made clear that k2, k3, and kx were all reduced
compared to the values in 1H2O, although the effect on k2
was only small (Table 3, fits in Figure 4B). The rate constant
k3 decreased from 0.8 to 0.2 s-1, by which it became the
slowest step in the reaction pathway. From these experi-
ments we can conclude that k3 becomes the rate-limiting step
when the reaction is performed in 2H2O and therefore
explains the solvent kinetic isotope effect.
Structure Modeling of D260N+N148E Dehalogenase.
Attempts to crystallize the mutant enzymes were not suc-
cessful. Amorphous precipitates were found upon incubation
under various crystallization conditions (I. Ridder, personal
communication). Therefore, mutations were modeled using
the X-ray structure of wild-type haloalkane dehalogenase as
a template (PDB entry code 1ede). This structure was
relaxed before modeling to remove the unfavorable atomic
kobs ) k-2 +
k2[X
-]
[X
-] + Ks
(7)
Kd )
K4k-5
k5 + k-5
(8)
FIGURE 5: Kinetics of bromide binding to the D260N+N148E
haloalkane dehalogenase double mutant, monitored by quenching
of the intrinsic tryptophan fluorescence (arbitrary units) of halo-
alkane dehalogenase. (A) Stopped-flow kinetic transients showing
tryptophan fluorescence (ìex ) 290 nm, ìem > 320 nm) upon mixing
5 íM enzyme with 0, 20, 40, 75, 125, and 450 mM NaBr in
T50EMAG buffer, pH 8.2 at 30 °C (end concentrations). These
traces could all be fitted to single-exponential equations. (B)
Observed rate constant kobs plotted as a function of the NaBr
concentration. (b) Data from the double mutant D260N+N148E.
The solid curve is a nonlinear least-squares fit of the data to a
hyperbola, kobs ) k-5 + k5([X-]/(K4 + [X-])) with k5 ) 620 ( 60
s-1, k-5 ) 48 ( 10 s-1, and K4 ) 1200 ( 300 mM. (O) Data and
fit from wild-type haloalkane dehalogenase [taken from Schanstra
and Janssen (1996)].
FIGURE 6: Kinetic scheme representing bromide export in wild-
type haloalkane dehalogenase (two parallel routes values, between
parentheses) and the double mutant D260N+N148E (lower route
only, values in boldface type). Rate constants could be derived
with an accuracy of 10-20% (see text).
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bonding network within the protein. A solvent layer and
tethering forces were used to optimize the structure gradually
and to avoid large deviations from the original X-ray
coordinates. The final minimization procedure converged
to an average derivative <0.0002 kcal mol-1 Å-1. Analo-
gous convergence was also achieved for the modeled
structure of the double mutant D260N+N148E and the
protein-substrate complexes.
The overall structure of the modeled double mutant closely
resembles the wild-type structure, except for some local
changes in the loops. The CR rms deviation between both
structures was 0.247 Å. The largest shifts in CR position
were 1.6, 1.26, and 1.35 Å observed for Pro196 (in the loop
between R-helices 6 and 7), Gly257 (in the loop between â-
strand 7 and R-helix 10), and Gly288 (in the loop between
â-strand 8 and R-helix 11), respectively.
The only observable differences between the model of the
double mutant and the wild-type structure in the local
environment around the modified residues and catalytic triad
are a 0.3-Å increase of the distance between His289N2 and
Asp124Oä1 and the loss of hydrogen bonds between residue
260 and Leu262 and between residue 260 and His289 (Figure
7). In addition, a new hydrogen bond was found between
Glu148O1 and His289Nä1, and the O1 atom of Glu148 is
located at about the same position as Asp260Oä2 in the wild-
type structure. The hydrogen-bonding network in this region
is summarized in Table 4 and Figure 7.
The substrate 1,2-dichloroethane (DCE) could be placed
into the active site of the model in the same way as in the
wild-type structure, indicating that the shape and size of both
cavities are similar.
DISCUSSION
On the basis of the X-ray structure and reaction mechanism
of haloalkane dehalogenase (DhlA), we proposed a role for
Asp260 in helping His289 to act as a general base in the
hydrolysis of the covalent intermediate. Mutation of Asp260
to asparagine indeed demonstrated that Asp260 is essential
for dehalogenase activity. In addition, our results implied
that the D260N mutant enzyme has structural differences
compared with the wild-type enzyme and that Asp260 plays
a critical structural role besides its catalytic function.
From the X-ray structure it is known that Asp260 is part
of two hydrogen-bonding networks (Figure 7; Verschueren
et al., 1993a). In the first one, Asp260Oä2 forms a salt bridge
with Nä1 of His289, and the histidine is further hydrogen-
bonded to a water molecule that hydrolyzes the covalent
intermediate emerging during substrate conversion. There-
fore, the ionic interaction between Asp260 and His289 is
supposed to be of catalytic importance, since it may facilitate
the proton extraction of the water molecule by His289 and
stabilize the positive charge on His289 electronically.
Structurally, Asp260 may provide hydrogen-bonding stabi-
lization of the functional His tautomer and thus secure its
correct orientation within the catalytic site as was found in
FIGURE 7: Stereoview of the active-site region of wild-type haloalkane dehalogenase (top) and the modeled double mutant D260N+N148E
(bottom). The hydrogen-bonding network is indicated by dashed lines. Notice the new hydrogen bond between residue 148 and His289,
which takes over the role of the lost bond between residue 260 and His289, the loss of the hydrogen bond between residue 260 and Leu262,
and the increased distance between His289 and Asp124 in the lower panel.
Table 4: Hydrogen Bonds Involving the Catalytic Triad Residues
in the Optimized Structure of Wild-Type Haloalkane Dehalogenase
and the Model of the D260N+N148E Double Mutant
distance (Å)
residue 1 atom residue 2 atom wild type D260N+N148E
Asp124 Oä2 Glu56 NH 2.01 1.94
Oä2 Trp125 NH 2.36 2.38
O Gly 127 NH 2.23 2.29
O Ala 128 NH 1.89 1.90
NH Asn 148 O 2.04 1.95
Glu 148 O2 Gly257 NH 2.46
O1 Asn260 Nä2H2 1.85
O1 Leu263 NH 1.95
O1 His 289 Nä1H 2.11
Asp260 Oä1 Lys261 NH 2.04
Oä1 Leu262 NH 1.88
Oä2 Asn 148 Nä2H1 1.94
Oä2 His289 Nä1H 1.97
Oä2 Leu263 NH 1.96
Asn260 Nä2H2 Glu148 O1 1.85
NH Gly257 O 2.20
His289 Nä1H Asp260 Oä2 1.97
O Val291 NH 2.37 2.24
Nä1H Glu148 O1 2.11
NH Trp194 O 2.11
9578 Biochemistry, Vol. 36, No. 31, 1997 Krooshof et al.trypsin (Sprang et al., 1987) and dienelactone hydrolase
(Cheah et al., 1993).
In the second hydrogen-bonding network, Asp260Oä2 is
hydrogen-bonded to Asn148Nä2 and Asn148 makes an
additional hydrogen bond with Asp124, which is the nu-
cleophile responsible for the formation of the alkyl-enzyme
intermediate (Verschueren et al., 1993a). Asn148 is thought
to have a special structural or functional role, since it has
unusual main-chain torsion angles (æ )- 9 ° ,ã)+ 94°).
The position of Asp260 is further stabilized by hydrogen
bonds from Oä1 to Leu262N and from Oä2 to Leu263N.
The many interactions in which the side chain of Asp260
is involved clearly suggest the importance of the residue in
maintaining the proper active-site geometry. By changing
Asp260 into asparagine, some of the hydrogen bonds would
surely be lost or weakened, thereby disrupting or destabiliz-
ing the hydrogen-bonding networks. This may lead to
conformational perturbations as was observed in phospho-
lipase A2 (Li & Tsai, 1993; Kumar et al., 1994). The
contribution of buried hydrogen-bonding networks to protein
stability was also demonstrated in acetylcholinesterase (Or-
dentlich et al., 1993), barnase (Chen et al., 1993), and lactate
dehydrogenase (Nobbs et al., 1994). In addition, the loss
of the negative charge in the D260N mutant may have
affected the delicate charge balance in the active site and
further destabilized the structure of the catalytic site.
Introduction of an additional negative charge as in the single
mutants N148D and N148E also resulted in a loss of stability.
The amino acid sequence alignment of DhlA with several
other R/â-hydrolase fold dehalogenases suggests that the triad
acid in the latter enzymes is present at a position equivalent
to Asn148 in DhlA. The different location of the triad acid
was also noticed in the lipase from the human pancreas
(Schrag et al., 1992). Activity could be restored partially to
the inactive D260N mutant dehalogenase by introducing the
additional N148D or N148E mutation. This indeed indicates
that an aspartic or glutamic acid at position 148 can act as
a triad acid, although catalytically less effectively. Appar-
ently, the charge balance and a sufficiently stabilizing
hydrogen-bonding network are restored in the active-site
cavity.
Pre-steady-state kinetic experiments with the
D260N+N148E double mutant clearly showed that the
mutations largely affected all reaction steps and not only k3.
The large decrease in k2 can be explained by the fact that
the affinity of Trp125 and Trp175 for halide ions is lower
than in the wild type, which may be accompanied by a
reduced transition-state stabilization during carbon-halogen
cleavage. The positions of Trp125 and 175 in the double
mutant do not seem to be different from the wild type, which
suggests that electronic rather than geometric perturbations
account for the decrease in k2.
The modeled structure of the double mutant showed that
Glu148O1 forms a hydrogen bond with His289Nä1 and that
the distance between His289 and Asp124 increased by 0.3
Å compared with the wild-type structure (Figure 7). This
trend would suggest that the catalytic water molecule can
be activated by His289 but that it is further away from its
target (Asp124Cç) in the alkyl-enzyme intermediate, resulting
in the slower hydrolysis of the covalent intermediate (k3).
Moreover, in the model the O1 atom of Glu148 appears to
be located at about the same position as Asp260Oä2 in the
wild-type structure (Figure 7). This means that the indole
ring of His289 is typically in the same plane as in the wild-
type structure and that only subtle changes in hydrogen
bonding and stabilization of the triad residues account for
the differences in kinetics, as was also the case for similar
mutants of Geotrichum candidum lipase (Schrag et al., 1994).
Two remarkable effects were observed on bromide export,
which is the slowest step in wild-type DhlA. The overall
bromide release is 12 times faster and is mechanistically
different in the mutant. Only one export route is observed
in the double mutant (Figure 6), while two parallel pathways
are proposed for the wild-type enzyme (Figure 6; Schanstra
& Janssen, 1996). In the most important (upper) route a
slow enzyme isomerization occurs prior to and after rapid
bromide dissociation. A slow unimolecular step, followed
by a fast bimolecular step, occurs in the second (lower)
export route. The bromide binding and release pathway
proposed for the double mutant is similar to the lower route
in wild-type DhlA. The large increase of the rate of this
pathway probably masks the existence of the alternative way
of bromide release.
The conformational changes associated with the uni-
molecular steps are still unknown. A small tunnel of which
Lys259, Asp260, and Lys261 form the wall was proposed
to connect the cavity with the solvent outside and to be
responsible for substrate entrance (Verschueren et al., 1993a).
Calculations of the molecular interaction fields between DhlA
and halide ions (Cl-,B r - ,I - ) predicted that Lys259 and
Lys261 could form a weak halide binding site at the surface
of the protein in front of the tunnel entrance (Damborsky ´e t
al., 1997). Bromide bound to this halide binding site could
represent the collision complex (EâX-)* in Figure 6. The
negative charge of Asp260, however, might hinder the export
of the halide ion through this tunnel, so that an additional,
more complex route is used in the wild-type enzyme. In
the D260N+N148E/D double mutants, however, the negative
charge has been shifted away from the tunnel by 2.6 Å,
enabling the halide ion to leave the active site through the
front door. The reduced binding affinity of Trp125 and
Trp175 for bromide ions would further increase the rate of
bromide release.
In addition, the hydrogen bond between the side chain of
residue 260 and Leu262N is lost in the modeled structure of
the double mutant, and the CR of Leu262 is shifted 0.6 Å
away from the tunnel (Figure 7, Table 4). The side chain
of Leu262 is proposed to block the tunnel in the wild-type
structure (Verschueren et al., 1993a). The shift of CR
together with the increased flexibility of the backbone of
Leu262 may enlarge the diameter of the tunnel and allow
faster exchange of the ions and water molecules between
the active site and the solvent.
Our results clearly demonstrate that the catalytic triad can
be rearranged in haloalkane dehalogenase. Schrag et al.
(1992) presume that the catalytic acid moved from â-strand
7 to strand 6 during the evolution of the lipases, because
pancreatic lipases, which are all of mammalian origin and
carry the acid on strand 6, are likely to be derivatives of the
lipoprotein lipases, which occur in various life forms and
have the acid on strand 7. The situation seems to be different
for the family of dehalogenases presented in Figure 2, since
they all are from bacterial sources. We propose that the shift
has taken place from â-strand 6 to strand 7 after this group
of dehalogenases had evolved. The fact that the double
mutants and the enzymes from the alignment are inactive
D260 and N148 Mutations in Haloalkane Dehalogenase Biochemistry, Vol. 36, No. 31, 1997 9579toward 1,2-dichloroethane would suggest that relocation of
the triad acid to strand 7 might have been an important event
in the adaptation of DhlA to 1,2-dichloroethane, a synthetic
compound that has not been emitted in large quantities into
the environment until its industrial production started in 1922.
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